[Diabetes mellitus: use of aspirin (AAS)].

Suppr

超能文献

作者信息

Lima Josivan Gomes de, Góis Lucina Teixeira de, Nóbrega Lúcia Helena Coelho

机构信息

Sociedade Brasileira de Endocrinologia e Metabologia.

出版信息

Rev Assoc Med Bras (1992). 2005 Jul-Aug;51(4):188-9. doi: 10.1590/s0104-42302005000400010. Epub 2005 Aug 24.

DOI:10.1590/s0104-42302005000400010

PMID:16127574

Abstract

摘要

相似文献

[Diabetes mellitus: use of aspirin (AAS)].

Rev Assoc Med Bras (1992). 2005 Jul-Aug;51(4):188-9. doi: 10.1590/s0104-42302005000400010. Epub 2005 Aug 24.

Primary vascular prevention: The end of the road for aspirin?

Diab Vasc Dis Res. 2018 Nov;15(6):475-476. doi: 10.1177/1479164118807988.

Aspirin therapy in diabetes mellitus.

Diabetologia. 1997 Jul;40(7):867.

[Updating the use of acetylsalicylic acid (ASA) in diabetes mellitus based upon evidence and focused on the patient].

Rev Assoc Med Bras (1992). 2006 Nov-Dec;52(6):388. doi: 10.1590/s0104-42302006000600014.

Aspirin therapy in diabetes.

Diabetes Care. 2004 Jan;27 Suppl 1:S72-3. doi: 10.2337/diacare.27.2007.s72.

Antiplatelet agents in the prevention of diabetic vascular complications.

Diabetes Metab Rev. 1993 Oct;9(3):177-88. doi: 10.1002/dmr.5610090303.

Aspirin: not currently for primary prevention in diabetes.

Int J Clin Pract. 2009 Jun;63(6):831-2. doi: 10.1111/j.1742-1241.2009.02105.x.

[Should one prescribe aspirin for all diabetics?].

Diabetes Metab. 1997 Dec;23(6):554-6.

[Underutilization of acetylsalicylic acid of cardiovascular prevention in patients with diabetes mellitus].

Med Clin (Barc). 2004 Jan 31;122(3):101-3. doi: 10.1016/s0025-7753(04)74157-3.

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.

JAMA. 2008 Nov 12;300(18):2180-1. doi: 10.1001/jama.2008.625. Epub 2008 Nov 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Diabetes mellitus: use of aspirin (AAS)].

Rev Assoc Med Bras (1992). 2005 Jul-Aug;51(4):188-9. doi: 10.1590/s0104-42302005000400010. Epub 2005 Aug 24.

Primary vascular prevention: The end of the road for aspirin?

Diab Vasc Dis Res. 2018 Nov;15(6):475-476. doi: 10.1177/1479164118807988.

Aspirin therapy in diabetes mellitus.

Diabetologia. 1997 Jul;40(7):867.

[Updating the use of acetylsalicylic acid (ASA) in diabetes mellitus based upon evidence and focused on the patient].

Rev Assoc Med Bras (1992). 2006 Nov-Dec;52(6):388. doi: 10.1590/s0104-42302006000600014.

Aspirin therapy in diabetes.

Diabetes Care. 2004 Jan;27 Suppl 1:S72-3. doi: 10.2337/diacare.27.2007.s72.

Antiplatelet agents in the prevention of diabetic vascular complications.

Diabetes Metab Rev. 1993 Oct;9(3):177-88. doi: 10.1002/dmr.5610090303.

Aspirin: not currently for primary prevention in diabetes.

Int J Clin Pract. 2009 Jun;63(6):831-2. doi: 10.1111/j.1742-1241.2009.02105.x.

[Should one prescribe aspirin for all diabetics?].

Diabetes Metab. 1997 Dec;23(6):554-6.

[Underutilization of acetylsalicylic acid of cardiovascular prevention in patients with diabetes mellitus].

Med Clin (Barc). 2004 Jan 31;122(3):101-3. doi: 10.1016/s0025-7753(04)74157-3.

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.

JAMA. 2008 Nov 12;300(18):2180-1. doi: 10.1001/jama.2008.625. Epub 2008 Nov 9.